Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years

Shares in Novo Nordisk fell more than 4% as its CEO laid out plans to launch new blockbuster drugs in the next few years while expanding into further treatment areas.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。